Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.
about
Application Progress of CRISPR/Cas9 System for Gene Editing in Tumor ResearchThe prognostic and functional role of microRNAs in acute myeloid leukemiaCancer stem cells in basic science and in translational oncology: can we translate into clinical application?Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy.PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features.The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome.Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogeneticsGenome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.Identification of novel genomic aberrations in AML-M5 in a level of array CGHImage cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspensionBone marrow necrosis in acute leukemia: Clinical characteristic and outcome.Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.Spectral karyotyping: an unique technique for the detection of complex genomic rearrangements in leukemia.Karyotype complexity and prognosis in acute myeloid leukemia.Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experienceA de novo acute myeloid leukemia (AML-M4) case with a complex karyotype and yet unreported breakpoints.Acute myeloid leukemia with adverse cytogenetic riskEpigenetics of hematopoiesis and hematological malignancies.Diagnostic microarrays in hematologic oncology: applications of high- and low-density arrays.CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.Unfavorable-risk cytogenetics in acute myeloid leukemia.Molecular markers in acute myeloid leukaemia.DDX6 and its orthologs as modulators of cellular and viral RNA expression.Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.Wanted DEAD/H or Alive: Helicases Winding Up in Cancers.Genetic and epigenetic heterogeneity and the impact on cancer relapse.XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiationClose correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia.Treatment of acute myeloid leukemia.A case report of acute myeloid leukemia and neurofibromatosis 1.Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia.Application of the AMLprofiler Diagnostic Microarray in the South African Setting.
P2860
Q26783442-30DC7051-1C64-4E38-85BC-4D45BA485754Q27693865-1E4F2F9C-933D-46E6-93CF-5E5AEF464283Q28081844-11B05ED9-9FA3-4D6A-96D4-AA4826C4073BQ33394269-0FC5D052-7A03-440D-A523-75DC98A79AFFQ33636086-E019B114-5E15-49E0-B242-89F3E168C841Q33728184-044CE1AC-E32D-4FE6-A5E6-6D628385C0EBQ34010735-60CB25F1-88A7-4B54-AAD7-ADE270ECD84FQ34167404-89A71D45-C3CA-4091-A811-C39BE264B6EDQ34205736-F2B4C243-EA22-4CC8-B082-335717F65CB0Q34248736-E2509187-BBB5-4D9D-98AA-6B4E2B912E15Q34386922-C575FE54-00FF-4B1D-A9AA-AC8EA92A7350Q34578265-1386C565-2166-409A-9642-FCABEF41B625Q35146475-A6926914-9922-45C1-A2C3-104613C0ABA3Q35256120-C772A77A-874C-45D7-8E24-857DE5FC7C74Q35987462-7B4F0011-F35A-4C1C-8B4F-5CD03CDEB75EQ36457184-636A42A0-8E48-454B-8026-89C51DA1A484Q36508647-3E454A32-1F82-4BFB-A30F-8FECB058693EQ36548075-1F5346BF-7467-4EDE-8E97-765812A1B24AQ36713551-877B63F4-496B-483C-9987-F1BC12B947BCQ36858928-7B13D7D5-55EB-4AD3-9488-5C4C10C5B61FQ37318679-70839680-06D9-4078-9CA2-D6B4ED870459Q37343797-414DFCDB-09E8-4C04-B176-936DC1795517Q37523893-87CFDDC4-CFBB-424D-AD74-A2AA2B2DEF46Q37587956-45500DAB-DBD3-4E90-B77A-00576C666097Q37592412-57E40FB2-F9F6-4AAE-82B8-59ABEDF54379Q37865545-60EC5A64-0D5D-4981-8978-994451BDDF2CQ38026007-F6811DC0-711C-408C-B76D-676A2FD551FAQ38208676-D8EE562B-5ADE-4CEC-A574-1861830C5E4BQ38352241-CEE0A76A-6BF1-4484-9215-2D8DF7E0B1D4Q38892311-07B4C07F-41A7-4C81-A0D2-EBBBE2CD1B0AQ38998990-8EEDD263-EC33-43FE-A843-89E1949E5C03Q39433546-0A22A404-1504-4A21-8F28-4A987E75AE95Q39643726-9F99FA64-B17F-4F03-9540-68E68A75BC46Q39708408-23F1965D-D4E5-4437-877A-174C9892C111Q39888679-68C8504F-588A-48A8-AE3E-57214C948AAFQ41197435-047B3169-8FC7-45AA-9B48-6794B4362FABQ41893399-A2ADD772-463C-409E-B2C9-21ABE55529B7Q43080898-D06A7B10-EDFD-4EE4-B4A7-38BB8C4E5183Q43410945-0121CD6C-79C5-4D01-ABBA-D4915B17545BQ47102086-5727149C-83E1-48EB-9843-A91983F52D9B
P2860
Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cytogenetic, molecular genetic ...... emia with a complex karyotype.
@ast
Cytogenetic, molecular genetic ...... emia with a complex karyotype.
@en
type
label
Cytogenetic, molecular genetic ...... emia with a complex karyotype.
@ast
Cytogenetic, molecular genetic ...... emia with a complex karyotype.
@en
prefLabel
Cytogenetic, molecular genetic ...... emia with a complex karyotype.
@ast
Cytogenetic, molecular genetic ...... emia with a complex karyotype.
@en
P2860
P1433
P1476
Cytogenetic, molecular genetic ...... emia with a complex karyotype.
@en
P2860
P304
P356
10.1053/J.SEMINONCOL.2008.04.007
P577
2008-08-01T00:00:00Z